What concentration should be used to administer a 2‑gram slow intravenous push of tranexamic acid?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 12, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Tranexamic Acid 2g Slow Push Concentration

For a 2-gram slow intravenous push of tranexamic acid, use a concentration of 100 mg/mL (standard formulation), which means administering 20 mL total volume over 10 minutes at a rate not exceeding 1 mL/minute.

Standard Dosing and Concentration

The FDA-approved formulation of tranexamic acid for intravenous use is 100 mg/mL in 10 mL single-dose vials (1000 mg per vial) 1. For a 2-gram dose, you would need two vials (20 mL total volume).

Administration Rate

Critical safety point: The infusion rate should not exceed 1 mL/minute to avoid hypotension 1. For a 2-gram dose (20 mL at 100 mg/mL concentration):

  • Minimum administration time: 20 minutes at 1 mL/min
  • This is slower than the typical "10-minute" bolus described in trauma guidelines

Context: Trauma Dosing Regimens

The most recent European trauma guidelines 2 and consensus statements 3 consistently recommend:

  • 1 gram loading dose over 10 minutes, followed by
  • 1 gram infusion over 8 hours

However, emerging evidence suggests higher initial dosing may be beneficial. The STAAMP trial data indicates that repeated dosing up to 3 grams total may be appropriate in hypotensive trauma patients 3. A recent 2025 joint position statement 4 notes that EMS agencies may administer either:

  • 1 g IV/IO dose (followed by hospital-based 1 g infusion over 8 hours), OR
  • 2 g IV/IO dose as an infusion or slow push

Practical Approach for 2g Dosing

If administering a 2-gram dose as a slow push:

  1. Use undiluted 100 mg/mL concentration (two 10 mL vials = 20 mL total)
  2. Administer over 20 minutes minimum (1 mL/min rate to prevent hypotension)
  3. Can be given as two sequential 1-gram doses over 10 minutes each if preferred
  4. Timing is critical: Must be given within 3 hours of injury 5, 2, 5—earlier is better, with benefit decreasing 10% for every 15-minute delay 5

Important Caveats

  • Do not exceed 1 mL/min infusion rate to avoid hypotension 1
  • Renal dosing adjustments required: For creatinine >1.36 mg/dL, reduce frequency or dose 1
  • Maximum safe dose appears to be 4 grams—thromboembolic risk increases significantly above this threshold (HR 5.33) 6
  • For intravenous use only—inadvertent neuraxial administration can cause seizures 1

The standard 100 mg/mL concentration should not be diluted for slow push administration, though it may be mixed with electrolyte solutions, carbohydrate solutions, or amino acid solutions if needed for infusion 1. Do not mix with blood products or penicillin-containing solutions 1.

Related Questions

What are the indications for tranexamic acid injection?
What is the recommended concentration of tranexamic acid (TXA) for rapid intravenous or intra‑osseous administration in a combat environment?
Can dexamethasone (corticosteroid) and tranexamic acid (antifibrinolytic) be administered simultaneously via intravenous (IV) infusion?
Can Tranexamic Acid (TXA) be administered intramuscularly (IM) and does the dose change?
For an 11-year-old child, is tranexamic acid 500 mg orally twice daily an excessive dose?
How should a previously healthy 21-year-old female presenting with fever, maculopapular rash, conjunctival injection, thrombocytopenia, and acute respiratory distress syndrome be managed?
In a 70‑year‑old patient with transthyretin cardiac amyloidosis, atrial fibrillation, and left‑atrial sludge after cardioversion while on rivaroxaban, what is the appropriate next step after switching to dabigatran 120 mg twice daily?
What is the recommended concentration of tranexamic acid (TXA) for rapid intravenous or intra‑osseous administration in a combat environment?
In a 25‑day‑old, 33‑week‑gestation male infant weighing 1.2 kg who suddenly developed bradycardia with cessation of spontaneous respiration (apnea), what is the most likely cause?
In a 74-year-old woman with an abdominal CT that incidentally reveals at least seven pulmonary nodules at both lung bases measuring up to 4 mm, what is the appropriate next step in management?
What is the differential diagnosis for a 16-year-old female presenting with multiple vesicular lesions on both the upper and lower lips?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.